Technology Developed at University of Houston Could Advance Treatment of Lymphoma
August 25, 2022
August 25, 2022
HOUSTON, Texas, Aug. 25 (TNSjou) -- The University of Houston issued the following news release:
* * *
Discovery Saves Valuable Time, Determines Success of CAR T-Cell Immunotherapy
* * *
In the war against cancer, one of the most critical battles is waged on a cellular level as T cells from the immune system are altered in the lab to attack cancer cells. This form of immunotherapy, called chimeric antigen receptor (CAR) T-cell therapy, can be a . . .
* * *
Discovery Saves Valuable Time, Determines Success of CAR T-Cell Immunotherapy
* * *
In the war against cancer, one of the most critical battles is waged on a cellular level as T cells from the immune system are altered in the lab to attack cancer cells. This form of immunotherapy, called chimeric antigen receptor (CAR) T-cell therapy, can be a . . .